Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2015 05:59 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Completion of Patient Enrollment in OPuS-2: a Clinical Trial of Avoralstat in Patients With HAE

RESEARCH TRIANGLE PARK, N.C., Oct. 8, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that it has completed enrollment in OPuS-2 (Oral ProphylaxiS-2), a blinded,...
October 08, 2015 05:58 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

Advancing once-daily BCX7353 into a Phase 2 trial in hereditary angioedema patients RESEARCH TRIANGLE PARK, N.C., Oct. 8, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)...
September 29, 2015 07:30 ET | Source: BioCryst Pharmaceuticals, Inc.

Sanj K. Patel Appointed to BioCryst's Board of Directors

RESEARCH TRIANGLE PARK, N.C., Sept. 29, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Sanj K. Patel was elected to the Company's Board of Directors. "On...
August 07, 2015 06:50 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Reports Second Quarter 2015 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 7, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter ended June 30, 2015. "During the...
August 06, 2015 07:30 ET | Source: BioCryst Pharmaceuticals, Inc.

Robert Ingram Appointed to BioCryst's Board of Directors

RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Robert A. Ingram was elected to the Company's Board of...
July 23, 2015 08:27 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Announce Second Quarter 2015 Financial Results August 7

RESEARCH TRIANGLE PARK, N.C., July 23, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its second quarter 2015 financial results will be released on Friday,...
June 18, 2015 12:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at the JMP Securities Life Sciences Conference

RESEARCH TRIANGLE PARK, N.C., June 18, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate summary...
June 17, 2015 06:50 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Licenses Worldwide Rights to Commercialize RAPIVAB(R) Influenza Treatment to CSL Limited

RESEARCH TRIANGLE PARK, N.C., June 17, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc., (Nasdaq:BCRX) and CSL Limited (ASX:CSL) (USOTC:CSLLY) – BioCryst Pharmaceuticals, Inc., a...
May 26, 2015 12:05 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst to Present at the Jefferies 2015 Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that executives from BioCryst are scheduled to provide a corporate summary...
May 13, 2015 06:58 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema

RESEARCH TRIANGLE PARK, N.C., May 13, 2015 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced the initiation of a Phase 1 clinical trial to evaluate the safety,...